<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib140">
 <element-citation publication-type="journal" id="sref140">
  <person-group person-group-type="author">
   <name>
    <surname>Whitehead</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Simpson</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Willcox</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Webley</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hay</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Butler</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wrixon</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bell</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bostock</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Little</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Griffiths</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial</article-title>
  <source>Pilot and Feasibility Studies</source>
  <volume>5</volume>
  <issue>1</issue>
  <year>2019</year>
  <fpage>98</fpage>
  <pub-id pub-id-type="doi">10.1186/s40814-019-0478-6</pub-id>
  <pub-id pub-id-type="pmid">31384480</pub-id>
 </element-citation>
</ref>
